Viking Therapeutics, Inc. (0VQA.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:53PM BST
| Previous close | 78.94 |
| Open | 80.47 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 73.21 - 80.47 |
| 52-week range | 8.79 - 99.29 |
| Volume | |
| Avg. volume | 10,491 |
| Market cap | 53.743M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.73 |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Viking Therapeutics, Inc. (NASDAQ:VKTX) is favoured by institutional owners who hold 72% of the company
Key Insights Significantly high institutional ownership implies Viking Therapeutics' stock price is sensitive to their...
Insider MonkeyViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Viking […]
- Thomson Reuters StreetEvents
Q1 2024 Viking Therapeutics Inc Earnings Call
Q1 2024 Viking Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.